Literature DB >> 15454972

Phylloquinone intake as a marker for coronary heart disease risk but not stroke in women.

A T Erkkilä1, S L Booth, F B Hu, P F Jacques, J E Manson, K M Rexrode, M J Stampfer, A H Lichtenstein.   

Abstract

OBJECTIVE: To examine the feasibility of using phylloquinone intake as a marker for coronary heart disease (CHD) and stroke risk in women. DESIGN AND
SETTING: Nurses' Health Study, a prospective cohort study during 1984-2000. Dietary data were collected in 1984, 1986, 1990, and 1994 using a validated semiquantitative food frequency questionnaire.
SUBJECTS: A total of 72 874 female nurses, aged 38-65 y, without previously diagnosed angina, myocardial infarction (MI), stroke, or cancer at baseline. MAIN OUTCOME MEASURES: Incidence of nonfatal MI, CHD deaths, total CHD events, ischemic, and total strokes.
RESULTS: There were 1679 CHD events (1201 nonfatal) and 1009 strokes (567 ischemic). After adjustment for age and lifestyle factors associated with cardiovascular disease risk, the multivariate relative risks (RR) (95% CI) of total CHD from the lowest to the highest quintile category of phylloquinone intake were 1 (reference), 0.80 (0.69-0.94), 0.86 (0.74-1.00), 0.77 (0.66-0.99), and 0.79 (0.68-0.92), P for trend=0.01. Further adjustment for dietary intakes of saturated fat, polyunsaturated fat, trans fatty acids, eicosapentaenoic, and docosahexaenoic acids, cereal fiber, and folate attenuated the association (RR comparing extreme quintiles 0.84 [0.71-1.00], P for trend=0.12). Incidence rates of total or ischemic strokes were not associated with phylloquinone intake.
CONCLUSION: The data suggest that high phylloquinone intake may be a marker for low CHD risk. Dietary and lifestyle patterns associated with phylloquinone intakes, rather than intake of the nutrient itself, might account for all or part of the weak association. .

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15454972     DOI: 10.1038/sj.ejcn.1602058

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  19 in total

1.  Phylloquinone and vitamin D status: associations with incident chronic kidney disease in the Framingham Offspring cohort.

Authors:  Conall M O'Seaghdha; Shih-Jen Hwang; Rachel Holden; Sarah L Booth; Caroline S Fox
Journal:  Am J Nephrol       Date:  2012-06-20       Impact factor: 3.754

Review 2.  The role of noninvasive cardiovascular testing, applied clinical nutrition and nutritional supplements in the prevention and treatment of coronary heart disease.

Authors:  Mark Houston
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-01-10

Review 3.  Dietary trans fatty acids and cardiovascular disease risk: past and present.

Authors:  Alice H Lichtenstein
Journal:  Curr Atheroscler Rep       Date:  2014-08       Impact factor: 5.113

Review 4.  Vitamin K nutrition, metabolism, and requirements: current concepts and future research.

Authors:  Martin J Shearer; Xueyan Fu; Sarah L Booth
Journal:  Adv Nutr       Date:  2012-03-01       Impact factor: 8.701

Review 5.  Vitamin K status and vascular calcification: evidence from observational and clinical studies.

Authors:  M Kyla Shea; Rachel M Holden
Journal:  Adv Nutr       Date:  2012-03-01       Impact factor: 8.701

Review 6.  Vitamin K-dependent carboxylation of osteocalcin: friend or foe?

Authors:  Caren M Gundberg; Jane B Lian; Sarah L Booth
Journal:  Adv Nutr       Date:  2012-03-01       Impact factor: 8.701

7.  Vitamins K and D status in stages 3-5 chronic kidney disease.

Authors:  Rachel M Holden; A Ross Morton; Jocelyn S Garland; Andrey Pavlov; Andrew G Day; Sarah L Booth
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-18       Impact factor: 8.237

8.  Vitamin K Status and Lower Extremity Function in Older Adults: The Health Aging and Body Composition Study.

Authors:  M Kyla Shea; Richard F Loeser; Fang-Chi Hsu; Sarah L Booth; Michael Nevitt; Eleanor M Simonsick; Elsa S Strotmeyer; Cees Vermeer; Stephen B Kritchevsky
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-11-17       Impact factor: 6.053

9.  Vitamin K, circulating cytokines, and bone mineral density in older men and women.

Authors:  M Kyla Shea; Gerard E Dallal; Bess Dawson-Hughes; José M Ordovas; Christopher J O'Donnell; Caren M Gundberg; James W Peterson; Sarah L Booth
Journal:  Am J Clin Nutr       Date:  2008-08       Impact factor: 7.045

10.  Effect of vitamin K supplementation on bone loss in elderly men and women.

Authors:  Sarah L Booth; Gerard Dallal; M Kyla Shea; Caren Gundberg; James W Peterson; Bess Dawson-Hughes
Journal:  J Clin Endocrinol Metab       Date:  2008-02-05       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.